Sunshine Holdings Plc · CSELK:SUN.N0000
Sunshine — Q1 FY2018 Earnings Presentation
19 slides from Sunshine's earnings presentation, Aug 4, 2018
Slide 1: Sunshine
IN Sunshine
Slide 2: Earnings Presentation 1QFY18
Earnings Presentation 1QFY18 04th August 2018
Slide 3: Forward Looking Statements
Forward Looking Statements This presentation contains forward-looking statements that are based on management’s current expectations and assumptions. Forward-looking statements include predictions of future results or activities and may contain the words “expects,” “believes,” “should,” “will,” “ant
Slide 4: Group Performance
Group Performance
Slide 5: Group at a Glance – 1QFY18 [Apr-Jun]
Group at a Glance – 1QFY18 [Apr-Jun] • LKR 5.2bn in Revenue; +12.5% YoY • LKR 541m PAT; +32.5% YoY • PATMI of LKR 224m; +8.7% YoY Revenue -1QFY18 • Healthcare revenue; LKR 1.9bn; -1.2% YoY Other, • Agri revenue; LKR 2.0bn; +19.8% YoY. FMC 3.2% Healthcare, G, 37.0% 3.0m kg of palm oil, +10.7% YoY.
Slide 6: Group Financial Highlights
Group Financial Highlights 1Q 1Q Growth LKR m FY18 FY17 % Revenue 5,200 4,621 12.5 EBIT 670 519 29.1 EBIT Margin 12.9% 11.2% Profit for the period 541 408 32.5 PAT Margin 10.4% 8.8% Profit Attributable to Equity owners 224 207 8.7 EPS (LKR) 1.68 1.54 8.7
Slide 7: 1Q Revenue Growth Trend
1Q Revenue Growth Trend • 5 Year CAGR of 11% 5 Yr CAGR: 11% Revenue growth 5,500 5,200 16% 5,000 15% 4,621 14% 4,500 4,179 13% 3,984 12% 4,000 10% 11% Revenue 3,473 LKR m 10% 3,500 3,000 8% Growth % 6% 2,500 5% 4% 2,000 1,500 2% 1,000 0% 1QFY14 1QFY15 1QFY16 1QFY17 1QFY18
Slide 8: 1Q Profitability
1Q Profitability PAT margins 600 10.4% 12.0% 500 8.8% 10.0% 8.2% 541 400 7.5% 8.0% 408 PAT LKR m 300 6.0% 326 314 3.6% 200 4.0% PAT margin % 100 2.0% 125 - 0.0% 1QFY14 1QFY15 1QFY16 1QFY17 1QFY18 • PAT at LKR 541m up 32.5% YoY, on the back of sales growth and operating margin improvement • Healthcar
Slide 9: Earnings Contribution
Earnings Contribution PAT -1QFY18 PATMI -1QFY18 Other, Other, 6.9% Healthcare, 12.7% FMCG, 15.4% Healthcare, 9.3% FMCG, 7.5% 37.7% LKR 541m LKR 224m Agri, Agri, 42.1% 68.4%
Slide 10: Segment Performance 1Q FY18
Segment Performance 1Q FY18
Slide 11: Healthcare
Healthcare 1Q 1Q Growth LKR m FY18 FY17 % Revenue 1,935 1,957 (1.2) EBIT 136 126 7.7 EBIT Margin 7.0% 6.4% Profit for the period 85 80 5.8 PAT Margin 4.4% 4.1% Highlights • 1QFY18 Revenue contracted by 1.2% YoY due to negative impact of NMRA price control • EBIT margin for 1QFY18 increased due to; •
Slide 12: Healthcare Retail
Healthcare Retail 23 Outlets existing outlets in Colombo, including 11 express outlets Highlights • Continued focus on Beauty and Wellness sales helped margin expansion • Strong growth in customer footfall • Consumer spending on healthcare and wellness is picking up
Slide 13: FMCG
FMCG 1Q 1Q Growth LKR m FY18 FY17 % Revenue 1,138 783 45.4 EBIT 69 48 45.3 EBIT Margin 6.1% 6.1% Profit for the period 51 42 22.5 PAT Margin 4.5% 5.3% Highlights • 1QFY18 Revenue growth of 45% YoY on the back of both volume & price growth • Strong growth in International business compared to same pe
Slide 14: Agri
Agri 1Q 1Q Growth LKR m FY18 FY17 % Revenue 1,988 1,659 19.8 EBIT 443 292 51.7 EBIT Margin 22.3% 17.6% Profit for the period 377 239 58.0 PAT Margin 19.0% 14.4% Highlights • Revenue growth in line with strategy of focusing on quality v/s quantity in tea and higher tea prices at the Colombo auction •
Slide 15: Other
Other Energy Packaging • Revenue of LKR 41m for • The packaging division 1QFY18 against LKR 25m for reported revenues of LKR the same period last year, due to the commencement of the 36m for 1QFY18 compared second power plant to LKR 102m same period last year • PAT of LKR 3m for 1Q FY18 against LKR
Slide 16: Additional data for analysts
Additional data for analysts 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q LKR m FY14 FY14 FY14 FY14 FY15 FY15 FY15 FY15 FY16 FY16 FY16 FY17 FY17 FY17 FY17 FY17 FY18 Revenue 3,473 3,498 3,743 3,982 3,984 4,166 4,072 4,105 4,179 4,341 4,288 4,615 4,621 5,056 4,425 5,115 5,199 PAT 125 236 415 350
Slide 17: Outlook
Outlook
Slide 18: Outlook for 2Q FY18
Outlook for 2Q FY18 Healthcare Agri • Focus on volume growth in • Tea prices likely to be firm Pharma, despite margin challenges • Focus on quality teas and crop • Focus on medical devices • Expected growth in Palm Oil crop, • More Beauty and Wellness sales in slight decrease in selling price Health
Slide 19: Thank you
Thank you For more information, Please visit our Investor Relations page http://www.sunshineholdings.lk/investor%20relations/index.php